Previous close | 4.4400 |
Open | 4.7400 |
Bid | 4.3450 x N/A |
Ask | 4.4800 x N/A |
Day's range | 4.3450 - 4.7400 |
52-week range | 4.3450 - 18.5286 |
Volume | |
Avg. volume | 0 |
Market cap | 196.774M |
Beta (5Y monthly) | 2.60 |
PE ratio (TTM) | N/A |
EPS (TTM) | -6.0600 |
Earnings date | 22 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Today, on 19 June 2024, the annual general meeting of Immunovia AB (publ) was held. A summary of the adopted resolutions follows below.
The shareholders in Immunovia AB (publ), Reg. No. 556730-4299, are hereby invited to the Annual General Meeting ("AGM") to be held at The Spark, Scheeletorget 1, Medicon Village, in Lund on Wednesday 19 June 2024 at 10 a.m. CEST.
The Board of Directors of Immunovia AB (publ) ("Immunovia" or the "Company") has today, subject to approval by the Annual General Meeting on 19 June 2024, resolved to carry out an issue of shares and warrants ("units") with preferential rights for the Company's existing shareholders of initially approximately SEK 70 million (the "Rights Issue"). The Company has received subscription undertakings amounting to a total of approximately SEK 1.3 million, corresponding to approximately 2 percent of th